Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hearing aids put to the test in small study

NCT ID NCT07667140

Symptom relief Sponsor: WSAUD A/S Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested custom in-the-ear hearing aids in 24 adults with mild-to-moderately severe sensorineural hearing loss. Participants were experienced hearing aid users who tried the study device and compared it to their own hearing aids. The goal was to measure speech understanding in quiet and noisy settings using standard hearing tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
In-the-Ear Hearing Aid
What this could lead to
If successful, this could confirm that custom in-the-ear hearing aids improve speech understanding in quiet and noisy settings for people with hearing loss.
What could go wrong
This is a small, completed post-market follow-up study with only 24 participants, so results may not apply to all hearing aid users. No major risks are expected since the device is already on the market.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Mar 2026

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Sensorineural hearing loss, mild-to-moderately severe (Pure tone average of 500, 1000, 2000 and 4000 Hz \<65). * Hearing loss should fall within fitting range of study hearing aid * Subjects should be experienced hearing aid users who have had and used hearing aids daily for at least 1 year. * Air-Bone-Gap should be less or equal to 20 dB. * Asymmetry between left and right ear should not exceed 20dB for frequencies in the range of 250Hz to 4kHz * Healthy (outer and middle) ear * Older than 18 years * German is mother tongue * Able to understand the instructions * Willing to participate in laboratory tests and to wear the study HAs at home for 2 weeks * Informed consent Exclusion Criteria: * Contraindication for HA treatment * Fluctuating or rapidly progressing hearing loss * "Central" hearing problems * Limited mobility * Limited dexterity (in handling the HA) * Known psychological or cognitive problems * Subjects must not show any injuries or a complete perforation of the ear drum. This must be clarified prior to the beginning of the study by means of otoscopy. * Subjects should be in good overall medical condition (e.g., they shall not suffer from dementia) and should not use medical treatments that might affect study results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss, sensorineural are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing loss, sensorineural

Contacts and locations

Locations

  • Hörzentrum Oldenburg gGmbH

    Oldenburg, Germany, 26129, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.